Use of an immunoglobulin G avidity assay based on recombinant antigens for diagnosis of primary Toxoplasma gondii infection during pregnancy
about
Diagnosis of parasitic diseases: old and new approachesEvaluation of recombinant SAG1, SAG2, and SAG3 antigens for serodiagnosis of toxoplasmosis.European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index.Sero-diagnostic evaluation of Toxoplasma gondii recombinant Rhoptry antigen 8 expressed in E. coliSeroreactivity to and avidity for recombinant antigens in toxoplasmosis.Use of dense granule antigen GRA6 in an immunoglobulin G avidity test to exclude acute Toxoplasma gondii infection during pregnancy.Use of recombinant antigens for early postnatal diagnosis of congenital toxoplasmosis.Epidemiology of and diagnostic strategies for toxoplasmosisChimeric antigens of Toxoplasma gondii: toward standardization of toxoplasmosis serodiagnosis using recombinant products.Use of immunoglobulin g avidity to determine the course of disease in visceral and post-kala-azar dermal leishmaniasis patients.A new MIC1-MAG1 recombinant chimeric antigen can be used instead of the Toxoplasma gondii lysate antigen in serodiagnosis of human toxoplasmosisResearch advances in microneme protein 3 of Toxoplasma gondii.Peptide microarray analysis of in silico-predicted epitopes for serological diagnosis of Toxoplasma gondii infection in humans.CCp5A Protein from Toxoplasma gondii as a Serological Marker of Oocyst-driven Infections in Humans and Domestic Animals.GRA2 and ROP1 recombinant antigens as potential markers for detection of Toxoplasma gondii-specific immunoglobulin G in humans with acute toxoplasmosis.Spiramycin treatment of Toxoplasma gondii infection in pregnant women impairs the production and the avidity maturation of T. gondii-specific immunoglobulin G antibodiesToxoplasma gondii recombinant antigens as tools for serodiagnosis of human toxoplasmosis: current status of studiesLimited value of assays using detection of immunoglobulin G antibodies to the two recombinant dense granule antigens, GRA1 and GRA6 Nt of Toxoplasma gondii, for distinguishing between acute and chronic infections in pregnant women.Review on the identification and role of Toxoplasma gondii antigenic epitopes.Immunochemical identification and detection of a 36-kDa Toxoplasma gondii circulating antigen in sera of infected women for laboratory diagnosis of toxoplasmosis.Serology using rROP2 antigen in the diagnostic of toxoplasmosis in pregnant women.Identification, production and assessment of two Toxoplasma gondii recombinant proteins for use in a Toxoplasma IgG avidity assayFactors associated with seropositivity for anti-Toxoplasma gondii antibodies in pregnant women of Londrina, Paraná, Brazil.Advances in serological, imaging techniques and molecular diagnosis of Toxoplasma gondii infection.Discovery of new Toxoplasma gondii antigenic proteins using a high throughput protein microarray approach screening sera of murine model infected orally with oocysts and tissue cysts.
P2860
Q33580745-698E030E-3DEB-414D-B765-EB88878E0CA6Q33639242-D4164923-A3B4-4B1C-A265-FD6CF454D059Q33753178-D1C20ED9-9832-4BCF-91DC-5FB5CDD1E69BQ33902694-2FFD5AB1-B15F-478B-A2DF-34732368133CQ33910692-C47FE09A-90D6-4EE6-ACD7-325497745065Q34150450-321C065D-7CC3-47EE-A994-D71F92CB5280Q34231671-8AF35A12-17D1-4C16-A96C-9A4951F039A6Q34267180-6AC455C7-8B78-48BE-8D4A-D553D0C84A82Q34719649-C111AFA0-AFCA-4162-A12C-8EE55B4A76D9Q34975018-D080722B-A769-4B4F-A97E-853BED23700EQ35666206-F7DEFBBF-51A5-41C4-9FD6-D3C64B5A1F83Q35875290-06E52967-04CC-4F2F-A974-98DBBC6BECAEQ36017737-93A0B4AB-94D3-4CAE-B4AA-382DEFE87A15Q36309668-9B462387-E524-4253-80E7-16A3A970DCF5Q37156733-46B42E3F-C53B-47FE-9698-2A61156514C7Q37374671-0C751C89-CD7F-4200-B6E8-8941F356F214Q37469581-ED122DCF-76B3-4D69-8EFA-ED8A91D7E9A1Q37594885-76B190EA-918F-4D64-A65D-B3196F8F7691Q38637651-4DAD7933-A8D0-4B60-B824-EFE6F6E567ECQ38883259-3C8EFE82-36DA-4696-9E24-CC9047FFC262Q39201461-B8906FE9-C82F-4E08-9AEC-ECE1FAD64C70Q41655795-730488DD-E657-4922-A580-7D73575B287CQ47832503-2CA28E60-3A73-4BBA-8668-C444B6E158F8Q48250464-3B3050F4-98A1-45AC-A1BA-F6C950CE23A3Q55645023-E719945B-504C-4593-8E57-ACB630FD1442
P2860
Use of an immunoglobulin G avidity assay based on recombinant antigens for diagnosis of primary Toxoplasma gondii infection during pregnancy
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Use of an immunoglobulin G avi ...... dii infection during pregnancy
@ast
Use of an immunoglobulin G avi ...... dii infection during pregnancy
@en
Use of an immunoglobulin G avi ...... dii infection during pregnancy
@nl
type
label
Use of an immunoglobulin G avi ...... dii infection during pregnancy
@ast
Use of an immunoglobulin G avi ...... dii infection during pregnancy
@en
Use of an immunoglobulin G avi ...... dii infection during pregnancy
@nl
prefLabel
Use of an immunoglobulin G avi ...... dii infection during pregnancy
@ast
Use of an immunoglobulin G avi ...... dii infection during pregnancy
@en
Use of an immunoglobulin G avi ...... dii infection during pregnancy
@nl
P2093
P2860
P50
P1476
Use of an immunoglobulin G avi ...... dii infection during pregnancy
@en
P2093
Andrea Spadoni
Elisa Beghetto
Mariassunta Del Pezzo
Nicola Gargano
Olga Minenkova
P2860
P304
P356
10.1128/JCM.41.12.5414-5418.2003
P407
P577
2003-12-01T00:00:00Z